Steve Blank Archives - Mediformatica

Calif.-based Artera, which offers an AI-enabled test aimed at personalizing therapy for prostate cancer patients, announces its launch alongside a $90 million investment.Johnson & Johnson, TIME Ventures, Koch Disruptive Technologies, Coatue, Walden Catalyst Ventures,…

Diverging trajectories of trust in healthcare and on-line information seeking: what’s next with LLMs

Weekly Roundup – January 31, 2026

Embedding clinical intelligence to help close care gaps

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

Tag: Steve Blank

Artera Launches with $90M for Multimodal AI, Predictive Cancer Tests

Artera launches with $90M to personalize prostate cancer therapy

Diverging trajectories of trust in healthcare and on-line information seeking: what’s next with LLMs

What impact has healow had on your organization and the patients’ experience?

Weekly Roundup – January 31, 2026

Embedding clinical intelligence to help close care gaps

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

Meditech founder Neil Pappalardo dies at 83

The Landscape of Mobile Apps for Healthy Eating: Case Study for a Systematic Review and Quality Assessment

Decagon raises $250M for AI agents, triples valuation to $4.5B

Successful AI adoption requires meaningful change management

The Safe AI in Medicaid Alliance can help providers hone their tactics

MediFormatica

News Aggregator